Analyst Price Targets — EOLS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 4, 2026 12:32 pm | Uy Ear | Mizuho Securities | $15.00 | $4.70 | TheFly | Evolus price target lowered to $15 from $19 at Mizuho |
| January 22, 2026 12:15 pm | — | BTIG | $13.00 | $4.90 | TheFly | Evolus price target lowered to $13 from $18 at BTIG |
| January 13, 2026 12:12 pm | Annabel Samimy | Stifel Nicolaus | $17.00 | $5.77 | TheFly | Evolus price target lowered to $17 from $20 at Stifel |
| December 1, 2025 9:34 pm | Vamil Divan | Mizuho Securities | $19.00 | $6.82 | StreetInsider | Evolus (EOLS) PT Lowered to $19 at Mizuho |
| October 3, 2024 6:57 am | Douglas Tsao | H.C. Wainwright | $27.00 | $17.05 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on Evolus (EOLS) |
| September 13, 2024 5:26 am | Balaji Prasad | Barclays | $20.00 | $16.46 | TheFly | Evolus price target raised to $20 from $16 at Barclays |
| September 13, 2024 5:11 am | Vamil Divan | Mizuho Securities | $25.00 | $16.46 | StreetInsider | Evolus (EOLS) PT Raised to $25 at Mizuho |
| January 29, 2024 3:32 am | Balaji Prasad | Barclays | $16.00 | $13.47 | StreetInsider | Barclays Upgrades Evolus (EOLS) to Overweight |
Latest News for EOLS
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced members of its management team will participate in a fireside chat and investor meetings at the upcoming Leerink Partners Global Healthcare Conference in Miami, FL. The fireside chat will take place on Wednesday, March 11, 2026, at 11:20…
Evolus (EOLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will report its fourth quarter and full-year 2025 financial results on Tuesday, March 3, 2026, after the U.S. financial markets close. Evolus management will host a conference call and live webcast to discuss these results at…
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio, today reported the grant during December 2025, January 2026, and February 2026 of an aggregate of 153,218 restricted stock units (RSUs) and 34,952 stock options of the company's common stock to 36 newly hired non-executive employees of the company. The awards were…
Shares of Evolus, Inc. (NASDAQ: EOLS - Get Free Report) have earned an average recommendation of "Moderate Buy" from the seven research firms that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and five have issued a buy rating
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for EOLS.
U.S. House Trading
No House trades found for EOLS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.